High Serum Brain-Derived Neurotrophic Factor Is Associated With Decreased Risks of Poor Prognosis After Ischemic Stroke

Background: BDNF (brain-derived neurotrophic factor) has been implicated in cardiovascular homeostasis and ischemic stroke pathogenesis. We aimed to prospectively investigate the associations between serum BDNF levels and the prognosis of ischemic stroke in a multicenter cohort study. Methods: This prospective study follows the STROBE reporting guideline. Serum BDNF concentrations were measured in 3319 ischemic stroke patients from the China Antihypertensive Trial in Acute Ischemic Stroke between August 2009 and May 2013 in 26 hospitals across China. The primary outcome was the composite outcome of death and major disability (modified Rankin Scale score ≥3) at 3 months after stroke onset. Multivariate logistic regression or Cox proportional hazards regression analysis was used to assess the associations between serum BDNF levels and adverse clinical outcomes. Results: During the 3-month follow-up period, 827 (24.92%) patients experienced a primary outcome, including 734 major disabilities and 93 deaths. After adjusting for age, sex, and other important prognostic factors, elevated serum BDNF levels were associated with decreased risks of primary outcome (odds ratio, 0.73 [95% CI, 0.58–0.93]), major disability (odds ratio, 0.78 [95% CI, 0.62–0.99]), death (hazard ratio, 0.55 [95% CI, 0.32–0.97]), and the composite outcome of death and vascular events (hazard ratio, 0.61 [95% CI, 0.40–0.93]) when 2 extreme tertiles were compared. Multivariable-adjusted spline regression analyses showed a linear association between serum BDNF levels and the primary outcome (P value for linearity=0.005). The addition of BDNF to conventional risk factors slightly improved reclassification for the primary outcome (net reclassification improvement: 19.33%; P<0.001; integrated discrimination index: 0.24%; P=0.011). Conclusions: Elevated serum BDNF concentrations were independently associated with decreased risks of adverse outcomes after ischemic stroke, suggesting that serum BDNF may be a potential biomarker for prognosis after ischemic stroke. Further studies are warranted to investigate the potential therapeutic benefit of BDNF for ischemic stroke.

[1]  N. Rezaei,et al.  Circulating brain-derived neurotrophic factor as a potential biomarker in stroke: a systematic review and meta-analysis , 2022, Journal of Translational Medicine.

[2]  M. Naghavi,et al.  Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019 , 2021, The Lancet. Public health.

[3]  D. Zozulinska-Ziolkiewicz,et al.  Brain-Derived Neurotrophic Factor and Diabetes , 2020, International journal of molecular sciences.

[4]  Wei Liu,et al.  Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities , 2020, Neural plasticity.

[5]  R. Delgado-Mederos,et al.  Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study , 2019, Translational Stroke Research.

[6]  B. Hempstead,et al.  BDNF Actions in the Cardiovascular System: Roles in Development, Adulthood and Response to Injury , 2019, Front. Physiol..

[7]  I. Benseñor,et al.  Post-stroke depression and cognitive impairment: Study design and preliminary findings in a Brazilian prospective stroke cohort (EMMA study). , 2019, Journal of affective disorders.

[8]  Y. Béjot,et al.  Brain-derived neurotrophic factor in peripheral blood mononuclear cells and stroke outcome , 2018, Experimental biology and medicine.

[9]  Li Gao,et al.  Low Serum Levels of Brain-Derived Neurotrophic Factor Were Associated with Poor Short-Term Functional Outcome and Mortality in Acute Ischemic Stroke , 2017, Molecular Neurobiology.

[10]  B. Machaliński,et al.  BDNF - A key player in cardiovascular system. , 2017, Journal of molecular and cellular cardiology.

[11]  J. Kaiser,et al.  Stability of BDNF in Human Samples Stored Up to 6 Months and Correlations of Serum and EDTA-Plasma Concentrations , 2017, International journal of molecular sciences.

[12]  K. Blennow,et al.  Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke , 2016, Stroke.

[13]  L. Wilkins.  Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community , 2016, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[14]  A. Lasek-Bal,et al.  Low Concentration of BDNF in the Acute Phase of Ischemic Stroke as a Factor in Poor Prognosis in Terms of Functional Status of Patients , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[15]  Y. Béjot,et al.  Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment , 2015, PloS one.

[16]  Z. Du,et al.  Brain-Derived Neurotrophic Factor Regulates TRPC3/6 Channels and Protects Against Myocardial Infarction in Rodents , 2015, International journal of biological sciences.

[17]  S. Cerdán,et al.  Brain-Derived Neurotrophic Factor Administration Mediated Oligodendrocyte Differentiation and Myelin Formation in Subcortical Ischemic Stroke , 2015, Stroke.

[18]  Yilong Wang,et al.  Associations Between Estimated Glomerular Filtration Rate and Stroke Outcomes in Diabetic Versus Nondiabetic Patients , 2014, Stroke.

[19]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[20]  P. Wolf,et al.  Serum Brain–Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Levels Are Associated With Risk of Stroke and Vascular Brain Injury: Framingham Study , 2013, Stroke.

[21]  L. Monteggia,et al.  Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders , 2012, Pharmacological Reviews.

[22]  L. Ferrucci,et al.  Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging , 2010, PloS one.

[23]  E. Lo,et al.  Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons , 2008, Proceedings of the National Academy of Sciences.

[24]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[25]  S. Rafii,et al.  Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. , 2005, The Journal of clinical investigation.

[26]  Stuart Maudsley,et al.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.

[27]  R. Kauppinen,et al.  Transgenic Mice Overexpressing Truncated trkB Neurotrophin Receptors in Neurons Show Increased Susceptibility to Cortical Injury after Focal Cerebral Ischemia , 2000, Molecular and Cellular Neuroscience.

[28]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[29]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[30]  Sudha Seshadri,et al.  Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. , 2014, JAMA neurology.

[31]  [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.

[32]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.